Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

Abstract Background Aberrant sialoglycans on the surface of tumor cells shield potential tumor antigen epitopes, escape recognition, and suppress activation of immunocytes. α2,3/α2,6Gal- and α2,6GalNAc (Gal/GalNAc)-linked sialic acid residues of sialoglycans could affect macrophage galactose-type le...

Description complète

Détails bibliographiques
Auteurs principaux: Jianmei Huang, Meiying Li, Bingjie Mei, Junyang Li, Yi Zhu, Qiaoshan Guo, Jianming Huang, Guonan Zhang
Format: Article
Langue:English
Publié: BMC 2022-10-01
Collection:Journal of Translational Medicine
Sujets:
Sialoglycans
Gal/GalNAc
Siglec-9
MGL
Tumor vaccine
TCR-Vβ repertoire
Accès en ligne:https://doi.org/10.1186/s12967-022-03714-y

Internet

https://doi.org/10.1186/s12967-022-03714-y

Documents similaires